SCHEMBL877655

SCHEMBL877655

CC(C)C1OC(C)(C)OCC1(C)C

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1474454 0.79
SCHEMBL11453338 0.78 CYP1A2 (0.30) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL11461227 0.75
SCHEMBL11464433 0.75
SCHEMBL11709969 0.71
SCHEMBL14256228 0.70
SCHEMBL22198001 0.69
SCHEMBL10764078 0.69 CYP1A2 (0.49) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL17931778 0.69
SCHEMBL11461226 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011101181-A1 PERFUME COMPOSITIONS HENKEL AG & CO. KGAA (DE) 2011-08-25 WO claimed
EP-1948773-A1 FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS Henkel AG & Co. KGaA (DE) 2008-07-30 EP claimed
WO-2007054177-A1 FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS HENKEL AG & CO. KGAA (DE) 2007-05-18 WO claimed
US-12275915-B2 Fragrance composition KAO CORPORATION (JP) 2025-04-15 US disclosed
US-20240294844-A1 FRAGRANCE COMPOSITION KAO CORPORATION (JP) 2024-09-05 US disclosed
EP-4361342-A1 PERFUME COMPOSITION Kao Corporation (JP) 2024-05-01 EP disclosed
US-11687000-B2 Sulfonium compound, chemically amplified resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-27 US disclosed
WO-2022270532-A1 PERFUME COMPOSITION 花王株式会社 2022-12-29 WO disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
EP-3914685-A1 MULTI-COMPONENT CLEANING SYSTEM Henkel AG & Co. KGaA (DE) 2021-12-01 EP disclosed
US-20210348088-A1 Multi-Component Cleaning System HENKEL AG & CO. KGAA (DE) 2021-11-11 US disclosed
EP-2020225-A2 Fragrance composition Kao Corporation (JP) 2009-02-04 EP disclosed
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; RESONAC CORPORATION (JP) 2008-04-10 US disclosed
US-20060165622-A1 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-07-27 US disclosed
US-20050245407-A1 Fragrance composition KAO CORPORATION (JP) 2005-11-03 US disclosed
CN-1674862-A Perfume composition KAO CORP (JP) 2005-09-28 CN disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed
EP-1552814-A1 FRAGRANCE COMPOSITION Kao Corporation (JP) 2005-07-13 EP disclosed
US-4220593-A 2-Cyclopropyl-4-isopropyl-2,5,5-trimethyl-1,3-dioxane as odorant HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 1980-09-02 US disclosed
US-4146506-A Perfume compositions with 4-isopropyl-5,5-dimethyl-1,3-dioxane HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 1979-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11687000-B2 Sulfonium compound, chemically amplified resist composition, and patterning process ETV6, PKD1, PKD2 CYP1A2 3279/4885CYP3A4 2747/4885CYP2C9 2486/4885
US-20080085251-A1 even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; TST, CYSLTR1, CYSLTR2 CYP1A2 373/4885CYP3A4 342/4885CYP2C9 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.